Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr 8;16(3):110-4.
doi: 10.1016/j.rpor.2011.02.006. eCollection 2011.

Application of IMRT in adjuvant treatment of soft tissue sarcomas of the thigh-Preliminary results

Anna Sladowska  1 , Marcin Hetnał  1 , Paweł Dymek  1 , Damian Kabat  1 , Kamil Kisielewicz  1 , Michał Wawrzak  1 , Paweł Zawadzki  1 , Jan Lesiak  1 , Edward Byrski  1 , Michał Waligórski  2
Affiliations

Application of IMRT in adjuvant treatment of soft tissue sarcomas of the thigh-Preliminary results

Anna Sladowska et al. Rep Pract Oncol Radiother. .

Abstract

Background: Fracture of the femur is the most frequent late complication in patients with soft tissue sarcomas (STS) who receive external beam radiotherapy after limb-sparing surgery.

Aim: To reduce the risk of bone fracture following radiotherapy of STS of the thigh, we minimized the dose to the femur and to surrounding normal tissues by applying intensity modulated radiation therapy (IMRT). We report preliminary results of post-surgery IMRT of the thigh in patients with STS in this extremity.

Materials and methods: 10 adult patients undergoing post-operative radiotherapy of STS of the thigh were treated using IMRT. Clinical IMRT plans with simultaneous integrated boost (SIB) and 3-phase three-dimensional conformal radiotherapy (3D-CRT) were designed to adequately treat the planning target volume and to spare the femur to the largest extent possible. Dose distributions and dose-volume histograms were compared.

Results: For either technique, a comparable target coverage was achieved; however, target volume was better covered and critical structures were better spared in IMRT plans. Mean and maximum doses to OAR structures were also significantly reduced in the IMRT plans. On average, the mean dose to the femur in 3D-CRT plans was about two times higher than that in IMRT plans.

Conclusion: Compared with 3D-CRT, the application of IMRT improves the dose distribution within the concave target volumes and reduces dose to the OAR structures without compromising target coverage.

Keywords: 3D-CRT; IMRT; Soft tissue sarcoma.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Example of transversal isodose distribution for a patient with soft tissue sarcoma of the thigh treated with: (A) 3D-CRT and (B) IMRT techniques.
Fig. 2
Fig. 2
Comparison of dose-volume histograms (DVH) for the patient of Fig. 1: (a) cumulative (b) differential in PTV1, PTV2 and PTV3 volumes for 3D-CRT and IMRT techniques used in treatment of this patient.
See this image and copyright information in PMC

References

    1. Krzakowski M. Polska Unia Onkologii; Warszawa: 2007. Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych. (Reccommended diagnostic and therapeutic procedures in treating malignant carcinomas – in Polish)
    1. DeVita V.T., Jr., Hellman S., Rosenberg S.A. 6th ed. Lippincott Williams & Wilkins; Philadelphia, PA: 2001. Cancer: principles and practice of oncology. p. 1841–91.
    1. Pisters P.W., O'Sullivan B., Maki R.G. Evidence-based recommendations for local therapy for soft tissue sarcomas. J Clin Oncol. 2007;25(8):1003–1008. - PubMed
    1. Yang J.C., Chang A.E., Baker A.R. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998;16(1):197–203. - PubMed
    1. Rosenberg S.A., Tepper J., Glatstein E. The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg. 1982;196(3):305–315. - PMC - PubMed